Analytical Data
-
基因名
MetC
- Application
-
别名
Beta-cystathionaseCysteine lyase
-
种属
Escherichia coli
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P06721
-
表达区间
1-392aa
-
分子量
46.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MetC, a critical component in bacterial metabolism and a key player in various biochemical pathways, has garnered significant attention in recent years due to its potential applications in biotechnology and medicine. The research on MetC recombinant proteins is primarily driven by the need to better understand its role in cellular processes and its interactions with other proteins. The unique properties of MetC, including its enzymatic activity and stability under varying conditions, make it an ideal candidate for recombinant expression systems. By utilizing techniques such as molecular cloning and protein engineering, scientists aim to produce MetC in high yields, facilitating the study of its functional mechanisms. Furthermore, recombinant MetC proteins can be utilized in the development of novel therapeutic approaches, including drug delivery systems and targeted therapies. As the field of synthetic biology advances, the capability to design and manipulate MetC can lead to innovative solutions in combating bacterial infections and enhancing industrial bioprocesses. Consequently, ongoing research focuses on optimizing production strategies, characterizing the protein's structure and function, and exploring its applications in various fields, paving the way for future advancements in protein-based technologies.
